Search

Your search keyword '"Armel Poda"' showing total 3 results
Start Over Author "Armel Poda" Journal journal of the international association of providers of aids care
3 results on '"Armel Poda"'

1. Future of HIV2 and HIV2 + 1 Infected Patients Treated with Antiretrovirals Followed at the Day Hospital HIV Care Unit from 2011 to 2015

Author

Ismaël Diallo MD, MPH, Smaïla Ouédraogo MD, PhD, Abdoulaye Sawadogo MD, MPH, Gafourou Arsène Ouédraogo MD, Eric Arnaud Diendéré MD, MPH, Jacques Zoungrana MD, Apoline Kongnimissom Sondo MD, Réné Bognounou MD, Mamoudou Savadogo MD, Armel Poda MD, Msc, MPH, and Youssouf Joseph Drabo MD

Subjects
Diseases of the genitourinary system. Urology, RC870-923
Abstract

Introduction: HIV2 is endemic in West Africa. In Burkina Faso, its prevalence was estimated at 2%. The aim of this work was to evaluate the follow-up of patients and also to contribute to the availability of data. Methods: We involved 18 years or older. Infection was screened according to the national algorithm. A cross- sectional study from first June 2017 to 31 December 2017 was performed. For each patient, sociodemographic, clinical, biological, therapeutic and evolution data were collected and analyzed. Results: The proportion of patients infected with HIV2 (n = 48; 1.7%) and HIV2 + 1 (n = 67; 2.4%) was 4.3%. The sex rat mean age was 50.3 ± 8.5 years. The combination of 2INTI + LPV/r was the most prescribed (n = 73; 63.5%). The average gain of LTCD4 has evolved from + 236 cells/mm 3 in 2011 to + 364 cells/mm 3 in 2015. The retention rate at grade 5 was about 70%. Conclusion: The immunological and clinic response of the patients was satisfactory. More than half of the patients remained in the continuum of care after five years of follow-up.

Published
2022
Full Text
View/download PDF

2. Profiles of Elderly People Infected with HIV and Response to Antiretroviral Treatment in Burkina Faso: A Retrospective Cohort Study

Author

Ismaël Diallo MD, Nicolas Meda MD, Smaïla Ouédraogo MD, Armel Poda MD, Arsène Hema MD, Yempabou Sagna MD, Lynda M. Sawadogo MD, Youssouf J. Drabo MD, and Dieu-Donné Ouedraogo MD

Subjects
Diseases of the genitourinary system. Urology, RC870-923
Abstract

Background: In sub-Saharan Africa, few studies exist on elderly HIV-positive populations. Therefore, we aimed to examine the profiles of elderly people living with HIV (PLHIV) in Burkina Faso and their response to antiretroviral therapy (ART). Methods: We reviewed the monitoring and treatment of PLHIV over the age of 50 years and then compared with the monitoring and treatment of PLHIV under 50 years. Results: A total of 3367 patients were included. The median age of elderly people was 54.5 years and of young people was 34.9 years ( P = .03). In both the groups, screening was performed following clinical suspicion (64.9% in elderly versus 56% in young people; P < .001). Cardiovascular risk factors were generally more significant in the elderly people. The risk of death while on ART was 2.3 times higher in elderly people ( P < .001). Conclusion: HIV infection in older people occurs in those who already have some cardiovascular risk factors. Particular attention should be given to multidisciplinary care for the elderly individuals.

Published
2017
Full Text
View/download PDF

3. Risk Factors for Early Mortality on Antiretroviral Treatment of Elderly People Infected with HIV in Burkina Faso

Author

Lynda Magali Sawadogo, Arsène Hema, Adrien Sawadogo, Ismael Diallo, Youssouf Joseph Drabo, Yempabou Sagna, Armel Poda, and Dieu-Donné Ouédraogo

Subjects
Adult, Male, Pediatrics, medicine.medical_specialty, Anti-HIV Agents, Immunology, Population, Human immunodeficiency virus (HIV), HIV Infections, Dermatology, medicine.disease_cause, Acquired immunodeficiency syndrome (AIDS), Burkina Faso, Antiretroviral treatment, Elderly people, Outpatient clinic, Medicine, Humans, education, Aged, Retrospective Studies, education.field_of_study, business.industry, Retrospective cohort study, Middle Aged, medicine.disease, CD4 Lymphocyte Count, Infectious Diseases, Female, business, Cohort study
Abstract

Background: Age is a key determinant of mortality due to diseases including HIV infection. Methods: A retrospective and descriptive cohort study used a computerized database to compare HIV-infected patients diagnosed in late adulthood to a group of patients diagnosed before their 49 years of age, without matching the characteristics of HIV infection. The study included patients who visited the day hospital (outpatient clinic) of the Sanou Souro Teaching Hospital of Bobo-Dioulasso, in Burkina Faso, from January 2007 to December 2011. Older adults were defined as those aged 50 years and more. Results: Participants in the study consisted of 2572 patients (265 older adults and 2307 young patients living with HIV. Based on Markov chain method, 32.1% of the older adults living with HIV were found to be seroconvert at 50 years or older. The median follow-up time on antiretroviral treatment (ART) was 32.7 months (range 0.03-65.4 months). Two hundred and ninety-five (11.5%) patients died, including 21.1% of older adults and 10.4% of young ( P < .01). World Health Organization stage 3 or 4 and the lowest CD4 count reached 3 were the factors associated with early mortality of older adults on ART. Conclusion: Mortality rate of older adult patients living with HIV in Burkina Faso is high. Early diagnosis, early treatment, and primary prevention of HIV infection in the older adults are the main keys that could help reduce such mortality.

Published
2014

Catalog

Books, media, physical & digital resources
See catalog results